Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

The re-emerging association between tuberculosis and diabetes: Lessons from past centuries.

Cadena J, Rathinavelu S, Lopez-Alvarenga JC, Restrepo BI.

Tuberculosis (Edinb). 2019 May;116S:S89-S97. doi: 10.1016/j.tube.2019.04.015. Epub 2019 May 3.

PMID:
31085129
2.

Molecular Modulation of Osteoblasts and Osteoclasts in Type 2 Diabetes.

Rathinavelu S, Guidry-Elizondo C, Banu J.

J Diabetes Res. 2018 Nov 4;2018:6354787. doi: 10.1155/2018/6354787. eCollection 2018. Review.

4.

NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH ADVANCED VISUAL LOSS TREATED WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY: Clinical Outcome and Prognostic Indicators.

Vogel RN, Davis DB, Kimura BH, Rathinavelu S, Graves GS, Szabo A, Han DP.

Retina. 2017 Feb;37(2):257-264. doi: 10.1097/IAE.0000000000001150.

PMID:
27429385
5.

Neurological recovery in patients of old healed tubercular rigid kyphosis with myelopathy treated with transpedicular decancellation osteotomy.

Basu S, Rathinavelu S.

Eur Spine J. 2012 Oct;21(10):2011-8. doi: 10.1007/s00586-012-2259-2. Epub 2012 Mar 29.

6.
7.

In vitro activities of a novel nanoemulsion against Burkholderia and other multidrug-resistant cystic fibrosis-associated bacterial species.

LiPuma JJ, Rathinavelu S, Foster BK, Keoleian JC, Makidon PE, Kalikin LM, Baker JR Jr.

Antimicrob Agents Chemother. 2009 Jan;53(1):249-55. doi: 10.1128/AAC.00691-08. Epub 2008 Oct 27.

8.

Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine.

Makidon PE, Bielinska AU, Nigavekar SS, Janczak KW, Knowlton J, Scott AJ, Mank N, Cao Z, Rathinavelu S, Beer MR, Wilkinson JE, Blanco LP, Landers JJ, Baker JR Jr.

PLoS One. 2008 Aug 13;3(8):e2954. doi: 10.1371/journal.pone.0002954.

9.

Helicobacter pylori-pulsed dendritic cells induce H. pylori-specific immunity in mice.

Zhang M, Berndt BE, Eaton KA, Rathinavelu S, Pierzchala A, Kao JY.

Helicobacter. 2008 Jun;13(3):200-8. doi: 10.1111/j.1523-5378.2008.00606.x.

10.

Helicobacter pylori-secreted factors inhibit dendritic cell IL-12 secretion: a mechanism of ineffective host defense.

Kao JY, Rathinavelu S, Eaton KA, Bai L, Zavros Y, Takami M, Pierzchala A, Merchant JL.

Am J Physiol Gastrointest Liver Physiol. 2006 Jul;291(1):G73-81. Epub 2006 Feb 9.

11.

Somatostatin inhibits dendritic cell responsiveness to Helicobacter pylori.

Kao JY, Pierzchala A, Rathinavelu S, Zavros Y, Tessier A, Merchant JL.

Regul Pept. 2006 Mar 15;134(1):23-9. Epub 2005 Dec 20.

PMID:
16375983
12.

Helicobacter pylori outer membrane protein 18 (Hp1125) induces dendritic cell maturation and function.

Rathinavelu S, Kao JY, Zavros Y, Merchant JL.

Helicobacter. 2005 Oct;10(5):424-32.

13.

Interferon gamma induction of gastric mucous neck cell hypertrophy.

Kang W, Rathinavelu S, Samuelson LC, Merchant JL.

Lab Invest. 2005 May;85(5):702-15.

14.

Chronic gastritis in the hypochlorhydric gastrin-deficient mouse progresses to adenocarcinoma.

Zavros Y, Eaton KA, Kang W, Rathinavelu S, Katukuri V, Kao JY, Samuelson LC, Merchant JL.

Oncogene. 2005 Mar 31;24(14):2354-66.

PMID:
15735748
15.

Treatment of Helicobacter gastritis with IL-4 requires somatostatin.

Zavros Y, Rathinavelu S, Kao JY, Todisco A, Del Valle J, Weinstock JV, Low MJ, Merchant JL.

Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12944-9. Epub 2003 Oct 10.

16.

Acinetobacter lwoffii infection and gastritis.

Rathinavelu S, Zavros Y, Merchant JL.

Microbes Infect. 2003 Jun;5(7):651-7. Review.

PMID:
12787741
17.

Does host complement kill Borrelia burgdorferi within ticks?

Rathinavelu S, Broadwater A, de Silva AM.

Infect Immun. 2003 Feb;71(2):822-9.

18.

Supplemental Content

Loading ...
Support Center